|
max fold increase
|
BAO_0080039 |
|
|
irritable bowel syndrome
|
DOID_9778 |
|
|
bioavailability assay
|
BAO_0002530 |
|
|
non-specific protein binding assay
|
BAO_0002531 |
|
|
tissue distribution assay
|
BAO_0002532 |
|
|
CCRF-CEM cell
|
CLO_0002334 |
|
|
HCT 116 cell
|
CLO_0003665 |
|
|
erysipelas
|
DOID_11330 |
|
|
IC20
|
BAO_0080001 |
|
|
697 cell
|
CLO_0001008 |
|
|
EC 1.10.3.1 (catechol oxidase) inhibitor
|
CHEBI_85049 |
|
|
EC 1.10.3.* (oxidoreductase acting on diphenols and related substances as donors with oxygen as acceptor) inhibitor
|
CHEBI_85048 |
|
|
organization role
|
BAO_0002590 |
|
|
IC25
|
BAO_0080002 |
|
|
chaperone coupled enzyme activity measurement method
|
BAO_0002591 |
|
|
IC30
|
BAO_0080003 |
|
|
T
|
BAO_0001260 |
|
|
abnormal retinal correspondence
|
DOID_12668 |
|
|
binocular vision disease
|
DOID_12667 |
|
|
Rac1 inhibitor
|
CHEBI_197347 |
|
